Doctor profile · Federal record
Dr. Mary Dobson, MD
Dermatology Physician (CMS: Dermatology) · Baton Rouge, LA
- NPI 1952392318
- Accepts Medicare
- MIPS 71.3 / 100 · 2023
- 30 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5326 Odonovan Drive
Baton Rouge, LA 708081452
(225) 769-7546
fax (225) 769-0471
Credentials & registration
- NPI registered
- November 2005 — 21 yrs on file
- Profile last updated
- April 30, 2008
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Louisiana #023067
- Medicaid
- LA #1483907
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1952392318. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,114
Distinct HCPCS
10
Medicare allowed
$154,979
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 9,000 | 17 | $2 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 484 | 343 | $86 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 350 | 81 | $6 | |
88305 |
Pathology examination of tissue using a microscope, intermediate complexity | 296 | 163 | $31 | |
11102 |
Biopsy of related skin growth, first growth | 211 | 168 | $83 | |
17110 |
Destruction of skin growth, 1-14 growths | 184 | 164 | $103 | |
17000 |
Destruction of precancer skin growth, 1 growth | 164 | 137 | $48 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 142 | 126 | $122 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 93 | 93 | $107 | |
11103 |
Biopsy of related skin growth, each additional growth | 70 | 43 | $47 |
In context: peer comparison
Among 15 peers in this city , average services per provider: 254. This provider delivers 44× the peer median.Open Payments
Industry payments received
All-time total
$928
Transactions
50
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GENZYME CORPORATION | 16 | $398.46 | |
| ABBVIE INC. | 16 | $164.65 | |
| Novartis Pharmaceuticals Corporation | 7 | $133.79 | |
| UCB, Inc. | 2 | $47.81 | |
| Arcutis Biotherapeutics, Inc. | 2 | $43.86 | |
| MIMEDX Group, Inc. | 1 | $29.02 | |
| Amgen Inc. | 1 | $23.91 | |
| Janssen Biotech, Inc. | 1 | $22.16 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $21.00 | |
| Dermavant Sciences, Inc. | 1 | $14.83 | |
| Biofrontera Inc. | 1 | $14.30 | |
| PFIZER INC. | 1 | $13.87 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
909
Patients
568
Total drug cost
$221,157
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Betamethasone Dipropionate | Generic | 100 | 55 | $5,932 |
| Spironolactone | Generic | 89 | 28 | $840 |
| Mupirocin | Generic | 84 | 69 | $623 |
| Ketoconazole | Generic | 75 | 54 | $1,473 |
| Fluconazole | Generic | 73 | 52 | $413 |
| Clobetasol Propionate | Generic | 69 | 49 | $4,076 |
| Triamcinolone Acetonide | Generic | 68 | 50 | $1,511 |
| Minoxidil | Generic | 54 | 17 | $272 |
| Dupixent Pen (Dupilumab) | Brand | 52 | 0 | $198,143 |
| Fluocinonide | Generic | 52 | 46 | $2,636 |
Frequently asked questions
What is Dr. Mary Dobson's medical specialty?
Dr. Mary Dobson practices Dermatology Physician in Baton Rouge, LA.
Where does Dr. Mary Dobson practice?
Dr. Mary Dobson practices at 5326 Odonovan Drive, Baton Rouge, LA 708081452. Office phone: 2257697546.
What is Dr. Mary Dobson's NPI?
Dr. Mary Dobson's National Provider Identifier (NPI) is 1952392318, issued by NPPES.
Does Dr. Mary Dobson accept Medicare assignment?
Yes. Dr. Mary Dobson accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mary Dobson commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.